Cite
Blocker displacement amplification-based genetic diagnosis for autosomal dominant polycystic kidney disease and the clinical outcomes of preimplantation genetic testing.
MLA
Lin, Tingting, et al. “Blocker Displacement Amplification-Based Genetic Diagnosis for Autosomal Dominant Polycystic Kidney Disease and the Clinical Outcomes of Preimplantation Genetic Testing.” Journal of Assisted Reproduction & Genetics, vol. 40, no. 4, Apr. 2023, pp. 783–92. EBSCOhost, https://doi.org/10.1007/s10815-023-02722-1.
APA
Lin, T., Luo, J., Yu, H., Dong, B., Zhang, Q., Zhang, W., Chen, K., Xiang, Y., Liu, D., & Huang, G. (2023). Blocker displacement amplification-based genetic diagnosis for autosomal dominant polycystic kidney disease and the clinical outcomes of preimplantation genetic testing. Journal of Assisted Reproduction & Genetics, 40(4), 783–792. https://doi.org/10.1007/s10815-023-02722-1
Chicago
Lin, Tingting, Junfeng Luo, Haibing Yu, Bohao Dong, Qi Zhang, Wei Zhang, Ke Chen, Yezhou Xiang, Dongyun Liu, and Guoning Huang. 2023. “Blocker Displacement Amplification-Based Genetic Diagnosis for Autosomal Dominant Polycystic Kidney Disease and the Clinical Outcomes of Preimplantation Genetic Testing.” Journal of Assisted Reproduction & Genetics 40 (4): 783–92. doi:10.1007/s10815-023-02722-1.